+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sangamo Therapeutics Inc - logo

Sangamo BioSciences is a biotechnology company that develops industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation. The company is focused on pioneering genetic cures for monogenic and infectious diseases by deploying its AAV-based gene therapy platform, and therapeutic genome editing and gene regulation platforms based on its novel zinc finger DNA-binding protein technology. Sangamo is headquartered in Richmond, California.

From
From
From
Sickle Cell Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Sickle Cell Disease Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
Hemophilia - Pipeline Insight, 2024 - Product Thumbnail Image

Hemophilia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Beta-thalassemia - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-thalassemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Thalassemia - Pipeline Insight, 2024 - Product Thumbnail Image

Thalassemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Sickle Cell Disease - Competitive landscape, 2023 - Product Thumbnail Image

Sickle Cell Disease - Competitive landscape, 2023

  • Report
  • May 2023
  • 196 Pages
  • Global
From
Car T-Cell Therapy Market 2024-2028 - Product Thumbnail Image

Car T-Cell Therapy Market 2024-2028

  • Report
  • June 2024
  • 162 Pages
  • Global
From
From
Loading Indicator